Period Ending |
Dec 31, 2014 |
Sep 30, 2014 |
Jun 30, 2014 |
Dec 31, 2013 |
Total Revenue |
– |
– |
– |
– |
Cost of Revenue |
– |
– |
– |
– |
|
Gross Profit |
– |
– |
– |
– |
|
|
Operating Expenses |
|
Research Development |
– |
– |
– |
– |
|
Selling General and Administrative |
33 |
51 |
1,326 |
2 |
|
Non Recurring |
– |
– |
– |
– |
|
Others |
– |
– |
– |
– |
|
|
|
Total Operating Expenses |
– |
– |
– |
– |
|
|
Operating Income or Loss |
(33) |
(51) |
(1,326) |
(2) |
|
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net |
– |
(850) |
– |
– |
|
Earnings Before Interest And Taxes |
(33) |
(901) |
(1,326) |
(2) |
|
Interest Expense |
– |
– |
– |
– |
|
Income Before Tax |
(33) |
(901) |
(1,326) |
(2) |
|
Income Tax Expense |
– |
– |
– |
– |
|
Minority Interest |
– |
– |
– |
– |
|
|
|
Net Income From Continuing Ops |
(33) |
(901) |
(1,326) |
(2) |
|
|
Non-recurring Events |
|
Discontinued Operations |
– |
– |
– |
– |
|
Extraordinary Items |
– |
– |
– |
– |
|
Effect Of Accounting Changes |
– |
– |
– |
– |
|
Other Items |
– |
– |
– |
– |
|
|
Net Income |
(33) |
(901) |
(1,326) |
(2) |
Preferred Stock And Other Adjustments |
– |
– |
– |
– |
|
Net Income Applicable To Common Shares |
(33) |
(901) |
(1,326) |
(2) |
|